indazoles has been researched along with Cholera Infantum in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choueiri, TK; Kaymakcalan, MD; Lalani, AA; Lin, X; McKay, RR; Simantov, R | 1 |
Berdel, WE; Bormann, E; Brümmendorf, TH; Crysandt, M; Gerss, J; Hartmann, W; Kessler, T; Kirsch, A; Koschmieder, S; Lenz, G; Mikesch, JH; Müller-Tidow, C; Pohlen, M; Schliemann, C; Stelljes, M; Vehring, K; von Stillfried, S; Wardelmann, E | 1 |
Berardi, R; Burattini, L; Cascinu, S; Conti, A; De Giorgi, U; Iacovelli, R; Muzzonigro, G; Pantano, F; Santini, D; Santoni, M | 1 |
Chang, HF; Chang, WT; Chao, PK; Chen, CT; Chen, SC; Cheng, MF; Chuang, JY; Law, PY; Loh, HH; Ou, LC; Shih, C; Tao, PL; Ueng, SH; Yeh, SH; Yeh, TK | 1 |
Ballesterosé, S; Martínez-Arrieta, R; Ramón, MF | 1 |
Bair, AH; Bycott, P; Chan, S; Joy, AA; Kim, S; Liau, KF; Lluch, A; Rosbrook, B; Rugo, HS; Soulieres, D; Stopeck, AT; Verma, S | 1 |
1 review(s) available for indazoles and Cholera Infantum
Article | Year |
---|---|
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials.
Topics: Adverse Drug Reaction Reporting Systems; Carcinoma, Renal Cell; Clinical Trials as Topic; Diarrhea; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Incidence; Indazoles; Indoles; Liver Neoplasms; Neoplasms; Niacinamide; Phenylurea Compounds; Pyrimidines; Pyrroles; Sorafenib; Sulfonamides; Sunitinib; Vomiting | 2014 |
2 trial(s) available for indazoles and Cholera Infantum
Article | Year |
---|---|
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML).
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Bone Marrow; Female; Gastrointestinal Diseases; Humans; Indazoles; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Microvessels; Middle Aged; Progression-Free Survival; Protein Kinase Inhibitors; Pyrimidines; Recurrence; Salvage Therapy; Sulfonamides; Treatment Outcome; Tumor Microenvironment | 2019 |
Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Hypertension; Imidazoles; Indazoles; Middle Aged; Mucositis; Neoplasm Proteins; Neutropenia; Protein Kinase Inhibitors; Receptors, Vascular Endothelial Growth Factor; Taxoids; Thrombophilia | 2011 |
3 other study(ies) available for indazoles and Cholera Infantum
Article | Year |
---|---|
Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.
Topics: Aged; Axitinib; Carcinoma, Renal Cell; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Interactions; Female; Gastrointestinal Diseases; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Proton Pump Inhibitors; Pyrroles; Sorafenib; Sunitinib; Survival Analysis; Treatment Outcome | 2017 |
1-(2,4-Dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one: A Novel Opioid Receptor Agonist with Less Accompanying Gastrointestinal Dysfunction than Morphine.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Gastrointestinal Diseases; Indazoles; Male; Mice; Mice, Inbred C57BL; Morphine; Receptors, Opioid | 2017 |
Oral tetridamine exposures.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Drug Overdose; Female; Gastrointestinal Diseases; Humans; Indazoles; Male; Middle Aged; Neurotoxicity Syndromes; Poison Control Centers; Retrospective Studies; Spain; Suicide, Attempted; Time Factors; Vaginal Douching; Young Adult | 2009 |